A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
Bristol-Myers Squibb
Bristol-Myers Squibb
Eli Lilly and Company
Canadian Cancer Trials Group
University of Arizona
Merck Sharp & Dohme LLC
Dartmouth-Hitchcock Medical Center
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)